ventilatorassoci
pneumonia
pilot
studi
huihwa
tsai
rn
msn
fangchi
lin
md
phd
shichuan
chang
md
phd
abstract
background
ventilatorassoci
pneumonia
vap
reduc
continu
andor
intermitt
subglott
suction
highlight
import
clearanc
oropharyng
secret
prospect
evalu
use
intermitt
suction
oral
secret
posit
chang
reduc
vap
method
timesequ
nonrandom
intervent
design
use
studi
consist
observ
phase
control
group
patient
educ
phase
follow
intervent
phase
studi
group
patient
occurr
vap
durat
mechan
ventil
length
intens
care
unit
icu
stay
mortal
record
result
vap
occur
less
frequent
studi
group
patient
control
group
patient
p
incid
rate
vap
control
studi
group
per
ventil
day
respect
p
vap
patient
ventil
day
day
day
p
respect
length
icu
stay
day
day
p
respect
control
studi
group
intermitt
suction
oral
secret
posit
chang
independ
factor
respons
decreas
vap
studi
group
stepwis
logist
regress
analysi
p
v
entilatorassoci
pneumonia
vap
common
nosocomi
infect
data
nation
nosocomi
infect
surveil
system
indic
vap
second
nosocomi
infect
urinari
tract
infect
affect
approxim
critic
patient
europ
vap
low
respiratori
tract
infect
account
infect
european
preval
infect
intens
care
studi
advanc
improv
diagnosi
treatment
prevent
vap
remain
signific
caus
mortal
addit
vap
associ
increas
morbid
prolong
durat
mechan
ventil
length
intens
care
unit
icu
stay
hospit
impact
medic
resourc
financ
estim
singl
vap
episod
prolong
durat
hospit
stay
day
even
longer
incur
addit
medic
expens
rang
us
dollar
per
patient
accordingli
effect
prevent
vap
lifesav
costeffect
measur
bacteri
colon
aerodigest
tract
aspir
contamin
secret
lower
airway
seem
essenti
process
pathogenesi
vap
continu
intermitt
subglott
suction
prove
use
reduc
vap
particular
earlyonset
vap
pool
secret
inflat
endotrach
tube
cuff
thought
major
sourc
aspir
find
highlight
adequ
clearanc
oral
secret
may
valu
reduc
occurr
vap
hypothesi
intermitt
suction
oral
secret
posit
chang
may
decreas
oral
secret
pool
endotrach
tube
cuff
aspir
contamin
secret
consequ
reduc
occurr
vap
studi
conduct
prospect
combin
medic
surgic
icu
januari
octob
consecut
patient
age
year
admit
combin
medic
surgic
icu
potenti
elig
studi
taipei
veteran
gener
hospit
patient
pneumonia
tracheostomi
endotrach
intub
mechan
ventil
hour
icu
admiss
endotrach
intub
mechan
ventil
admiss
hour
icu
without
endotrach
intub
mechan
ventil
icu
exclud
studi
consist
observ
phase
educ
phase
follow
intervent
phase
januari
septemb
patient
fulfil
patient
select
criteria
classifi
control
group
figur
octob
march
nurs
staff
icu
inform
studi
would
done
staff
would
execut
intervent
complianc
intervent
would
maintain
high
enough
chang
bodi
posit
everi
hour
except
routin
mouth
care
earli
morn
routin
nurs
protocol
icu
intervent
suction
oral
secret
posit
chang
suction
oral
secret
allow
clinic
indic
suction
oral
secret
perform
clear
oral
secret
complet
possibl
suction
tube
extend
oropharyng
space
accordingli
patient
studi
group
receiv
addit
time
suction
oral
secret
complianc
intermitt
suction
oral
secret
monitor
selfreport
check
randomli
senior
staff
educ
phase
intervent
phase
studi
start
april
complianc
intervent
time
everi
staff
april
octob
patient
met
select
criteria
classifi
studi
group
figur
institut
review
board
taipei
veteran
gener
hospit
approv
studi
written
inform
consent
obtain
patient
patient
next
kin
studi
period
intervent
phase
nurs
staff
remind
everyday
execut
intervent
precis
monitor
close
senior
staff
intervent
start
patient
admit
icu
end
case
day
icu
admiss
extub
perform
tracheostomi
death
icu
discharg
icu
semirecumb
posit
head
elev
greater
part
nurs
care
protocol
icu
except
contraind
differ
nurs
care
protocol
control
studi
group
interventionsuct
oral
secret
posit
chang
follow
data
record
demograph
data
primari
reason
icu
admiss
acut
physiolog
chronic
health
evalu
ii
score
occurr
infect
hospit
use
antibiot
report
risk
factor
vap
outcom
measur
includ
occurr
incid
rate
vap
durat
mechan
ventil
length
icu
stay
mortal
vap
diagnos
base
presenc
new
andor
progress
pulmonari
infiltr
chest
radiograph
plu
follow
criteria
fever
bodi
temperatur
hypothermia
bodi
temperatur
leukocytosi
l
purul
tracheobronchi
secret
pao
fio
mm
hg
last
hour
accord
definit
center
diseas
control
prevent
continu
variabl
express
mean
standard
deviat
statist
comparison
independ
group
perform
use
student
test
mannwhitney
u
test
appropri
comparison
categori
data
group
made
use
test
statist
test
twotail
independ
factor
reduc
vap
assess
stepwis
logist
regress
analysi
signific
defin
p
statist
analysi
perform
use
spss
version
spss
chicago
il
studi
patient
control
group
patient
studi
group
demograph
clinic
data
control
studi
group
summar
tabl
signific
differ
group
except
surgic
patient
enrol
control
group
vap
occur
less
frequent
studi
group
control
group
p
tabl
similarli
incid
rate
vap
significantli
lower
studi
control
group
versu
per
ventil
day
p
onset
vap
rang
day
median
day
control
group
day
median
day
studi
group
note
durat
mechan
ventil
significantli
reduc
studi
group
length
icu
stay
also
decreas
studi
group
howev
differ
reach
statist
signific
determin
independ
factor
respons
reduct
vap
studi
group
variabl
p
valu
list
tabl
intervent
intermitt
suction
oral
secret
posit
chang
analyz
stepwis
logist
regress
analysi
intermitt
suction
oral
secret
posit
chang
independ
factor
reduct
vap
ci
p
comparison
demograph
clinic
data
vap
patient
control
studi
group
shown
tabl
compar
control
group
durat
mechan
ventil
length
icu
stay
significantli
reduc
studi
group
potenti
pathogen
vap
yield
cultur
endotrach
aspir
control
studi
group
shown
tabl
growth
found
case
control
group
studi
group
microorgan
yield
cultur
endotrach
aspir
vap
patient
studi
appear
pathogen
lateonset
vap
although
none
vap
occur
day
endotrach
intub
mechan
ventil
preliminari
result
indic
intermitt
suction
oral
secret
posit
chang
might
significantli
reduc
vap
occurr
incid
icu
patient
intervent
independ
factor
decreas
vap
addit
durat
mechan
ventil
length
icu
stay
vap
patient
significantli
reduc
studi
group
find
suggest
intermitt
suction
oral
secret
posit
chang
may
attract
prevent
measur
vap
firm
bodi
evid
oropharyng
colon
pivot
pathogenesi
vap
link
increas
sever
ill
higher
occurr
oropharyng
colon
increas
risk
develop
vap
report
subsequ
studi
confirm
oropharyng
colon
risk
factor
vap
evid
support
studi
demonstr
decreas
vap
occurr
incid
continu
andor
intermitt
subglott
suction
accordingli
plausibl
adequ
clearanc
oral
secret
may
valu
reduc
oropharyng
colon
subsequ
develop
vap
support
concept
result
show
intermitt
suction
oral
secret
posit
chang
could
significantli
reduc
vap
occurr
p
incid
rate
episod
per
ventil
day
p
icu
patient
vap
signific
decreas
durat
mechan
ventil
length
icu
stay
found
studi
group
tabl
durat
mechan
ventil
length
icu
stay
vap
patient
decreas
day
respect
studi
group
taken
togeth
intermitt
suction
oral
secret
posit
chang
could
reduc
vap
occurr
incid
lessen
sever
vap
icu
patient
vap
remain
clinic
challeng
physician
involv
critic
care
despit
improv
understand
recent
advanc
diagnosi
prevent
manag
strategi
diseas
vap
occur
intub
patient
agreement
report
vap
occur
patient
control
group
rel
low
occurr
vap
studi
may
explain
part
follow
reason
hand
hygien
educ
infect
control
promot
aggress
due
impact
sever
acut
respiratori
syndrom
taiwan
semirecumb
posit
head
elev
greater
prove
use
reduc
vap
part
routin
care
protocol
icu
year
earlyonset
vap
found
studi
limit
studi
first
random
control
studi
case
studi
may
larg
enough
heterogen
patient
studi
conduct
combin
medic
surgic
icu
may
confound
result
effect
intervent
valu
intermitt
suction
oral
secret
posit
chang
reduc
lateonset
vap
remain
unknown
lateonset
vap
found
studi
howev
result
present
studi
clinic
relev
patient
studi
came
icu
treat
protocol
except
intervent
evalu
studi
group
may
decreas
avoid
inher
bia
caus
differ
patient
popul
nurs
protocol
qualiti
medic
nurs
staff
particular
multicent
studi
studi
conduct
simultan
differ
icu
hospit
prospect
random
studi
larger
popul
need
verifi
issu
conclus
intermitt
suction
oral
secret
posit
chang
may
significantli
reduc
vap
occurr
incid
decreas
durat
mechan
ventil
length
icu
stay
vap
patient
clinic
benefit
intermitt
suction
oral
secret
posit
chang
need
studi
larger
popul
verifi
